ArticlePloS one2015

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.

Renske Altena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.